You just read:

CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data to be Presented at the American Society of Clinical Oncology 2018 Annual Meeting

News provided by

CytRx Corporation

May 17, 2018, 09:00 ET